Por: Los Angeles Times Science September 30, 2022
Dr. Steven-Huy Han, a UCLA liver specialist, has prescribed Ocaliva to a handful of patients, although he’s not sure it helps. As advertised, the drug is lowering levels of an enzyme called alkaline phosphatase in their blood, and that should be a sign of healing for their autoimmune disease, called primary biliary cholangitis. But “no one knows for sure,” Han said, whether less enzyme means they won’t get liver cancer or cirrhosis in... + full article
Forbes USA Business September 30, 2022
, VP and Business Leader, Infovision Social—the Research, Digital Experience, Social Media Analytics arm of InfoVision. getty Social media has opened up a whole new dimension of insights for pharma companies. The conversations happening in social media are real-world... + más
Council Post: 10 Areas To Dedicate The Bulk Of Your Social Media Budget To (And Why) | Forbes
Cadence Brings Big Data And AI Analytics To SoC Verification | Forbes
ABC News USA Health September 30, 2022
WASHINGTON -- A much-debated drug for Lou Gehrig’s disease won U.S. approval Thursday, a long-sought victory for patients that is likely to renew questions about the scientific rigor behind government reviews of experimental medicines.Amylyx Pharmaceuticals said the Food and... + más
Highly debated Amylyx Pharmaceuticals ALS drug wins FDA approval | New York Post
ALS drug wins FDA approval despite questionable data | WPLG Local 10
New York Post USA Life September 30, 2022
A much-debated drug for Lou Gehrig’s disease won US approval on Thursday from the Food and Drug Administration. The nod represents a long-desired victory for patients, though it is likely to renew questions about the scientific rigor behind government reviews of... + más
ALS drug wins FDA approval despite questionable data | ABC News
ALS drug gets FDA approval despite uncertainty about effectiveness | ABC7
10 WBNS USA Nation September 30, 2022
WASHINGTON — A for Lou Gehrig’s disease won U.S. approval Thursday, a long-sought victory for patients that is likely to renew questions about the scientific rigor behind government reviews of experimental medicines. The Food and Drug Administration approved the drug from... + más
WPLG Local 10 USA Politics September 30, 2022
WASHINGTON – A much-debated drug for Lou Gehrig’s disease won U.S. approval Thursday, a long-sought victory for patients that is likely to renew questions about the scientific rigor behind government reviews of experimental medicines.The Food and Drug Administration approved... + más
Associated Press USA Science September 30, 2022
WASHINGTON (AP) — A much-debated drug for Lou Gehrig’s disease won U.S. approval Thursday, a long-sought victory for patients that is likely to renew questions about the scientific rigor behind government reviews of experimental medicines.The Food and Drug Administration... + más
ABC News USA Health September 21, 2022
The Food and Drug Administration is warning parents and teens about very unsafe social media trends, including a recent one that has begun trending online involving cooking chicken in NyQuil.The challenge -- which the FDA called “silly and unappetizing” and “very unsafe”... + más
FDA concedes delays in response to baby formula shortage | ABC News
FDA concedes delays in response to baby formula shortage | Associated Press
About iurex | Privacy Policy | Disclaimer |